Skip to main navigation Skip to search Skip to main content

Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real-world evidence

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Downloads (Pure)
Original languageEnglish
Pages (from-to)2026-2027
Number of pages2
JournalJEADV : journal of the European Academy of Dermatology and Venereology
Volume39
Issue number12
DOIs
Publication statusPublished - Dec 2025

Cite this